![How Al Gilman Taught Texas a Lesson in Science](https://cdn.cancerletter.com/media/2016/07/art-42-04-kpg-cprit.jpg)
![How Al Gilman Taught Texas a Lesson in Science](https://cdn.cancerletter.com/media/2016/07/art-42-04-kpg-cprit.jpg)
Cover Story
Free
This series re-examines the concurrent controversies at the Cancer Prevention and Research Institute of Texas and MD Anderson Cancer Center. This examination is possible in part because of new insight provided by Alfred Gilman, the Nobel laureate who served as the first scientific director of the state institution that distributes $300 million a year. Gilman died on Dec. 23, 2015.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Drugs & Targets
Trending Stories
- Edward Sondik, electrical engineer turned public health expert and one-time interim NCI director, dies at 82
- Trump et al. are wrong: Biden Cancer Initiative is not to be confused with the Beau Biden Cancer Moonshot
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers
- High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forward
NCI’s Youth Enjoy Science (YES) program also invests in student scientists - How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission